# US 2024/0198127 A1 · Light delivery device and method for ultrasound guided interstitial photodynamic therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198127 A1
- Document ID: US20240198127A1
- Status: Published application
- Kind: A1
- Application number: 18/557,950
- Filed: 2022-05-02
- Published: 2024-06-20
- Earliest claimed: 2021-04-30
- Applicants: Health Research, Inc.
- Inventors: Sergei KURENOV; Gal SHAFIRSTEIN; Nathaniel IVANICK; David BELLNIER; Lawrence TWOREK
- Web page: https://patentgrep.com/patent/US20240198127A1

## CPC

- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61N 5/0601: {Apparatus for use inside the body}
- A61N 2005/0626: {Monitoring, verifying, controlling systems and methods}
- A61N 2005/063: {comprising light transmitting means, e.g. optical fibres}
- A61N 2005/0632: {Constructional aspects of the apparatus}
- A61N 2005/0659: {infrared}
- A61N 2005/0662: {Visible light}
- A61N 2005/0663: {Coloured light}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A device includes a first fiber lock configured to be attached to a handle of an EUS-NA device and to selectively lock or unlock a fiber optic cable in position with respect to a sample needle. A second fiber lock is configured to be attached to abase of the EUS-NA device and to selectively lock or unlock a fiber optic cable in position. A method includes passing a fiber optic cable through a passage of the EUS-NA device such that an end of the fiber optic cable is at a tip of a sample needle of the EUS-NA device. The fiber optic cable is locked relative to the sample needle, and the sample need is advanced into the target tissue. The fiber optic cable is unlocked from the sample needle and locked relative to abase of the EUS-NA device. The sample needle is retracted such that the end of the fiber optic cable remains in the target tissue.

## Claims

### Claim 1

A device for delivering light to a target tissue, comprising:
a first fiber lock configured to be attached to a handle of an EUS-NA device, and wherein the first fiber lock is configured to selectively lock or unlock a fiber optic cable in position with respect to a sample needle of the EUS-NA device;
a second fiber lock configured to be attached to a base of the EUS-NA device, and wherein the second fiber lock is configured to selectively lock or unlock a fiber optic cable in position with respect to a body of the EUS-NA device.

### Claim 2 (depends on 1)

The device of claim 1, wherein the EUS-NA device is an EBUS-TBNA device or a EUS-FNA device.

### Claim 3 (depends on 1)

The device of claim 1, further comprising a frame configured to be attached to the base of the EUS-NA device.

### Claim 4 (depends on 3)

The device of claim 3, wherein frame comprises a lower bracket for attachment to the base of the EUS-NA device, an upper frame to which the second fiber lock is attached, and one or more rods connecting the lower bracket to the upper bracket.

### Claim 5 (depends on 4)

The device of claim 4, wherein the frame further comprises a middle bracket configured to slide along the one or more rods, wherein the middle bracket is configured to be attached to the handle of the EUS-NA device, and wherein the first fiber lock is attached to the middle bracket.

### Claim 6 (depends on 1)

The device of claim 1, wherein the first fiber lock and the second fiber lock are luer lock components.

### Claim 7 (depends on 1)

The device of claim 1, further comprising an EUS-NA device, wherein the middle bracket is attached to a handle of the EUS-NA device, and the lower bracket is attached to a base of the EUS-NA device.

### Claim 8 (depends on 1)

The device of claim 1, wherein the fiber optic cable comprises a first optical fiber and a second optical fiber.

### Claim 9 (depends on 8)

The device of claim 8, wherein the first optical fiber and the second optical fiber are made from a bifurcated optical fiber.

### Claim 10 (depends on 8)

The device of claim 8, further comprising a light source in optical communication with the first optical fiber for delivery of light to the tissue.

### Claim 11 (depends on 10)

The device of claim 10, wherein the light source is configured for photodynamic therapy.

### Claim 12 (depends on 11)

The device of claim 11, wherein the light source has a wavelength of 400 nm to 1200 nm, or 600 nm to 800 nm, or 630 nm.

### Claim 13 (depends on 10)

The device of claim 10, wherein the light source is a measurement light source.

### Claim 14 (depends on 13)

The device of claim 13, wherein the light source is a white light source.

### Claim 15 (depends on 10)

The device of claim 10, further comprising a light detector in optical communication with the second optical fiber for measuring light received from the tissue.

### Claim 16 (depends on 15)

The device of claim 15, wherein the light detector is a spectrometer.

### Claim 17

A method for delivering light to a target tissue, comprising:
passing a fiber optic cable through a passage of the EUS-NA device such that an end of the fiber optic cable is at a tip of a sample needle of the EUS-NA device;
locking the fiber optic cable relative to the sample needle such that the fiber optic cable moves with the sample needle;
advancing the sample needle into the target tissue;
unlocking the fiber optic cable from the sample needle and locking the fiber optic cable relative to a base of the EUS-NA device; and
retracting the sample needle, wherein the end of the fiber optic cable remains in the target tissue.

### Claim 18 (depends on 17)

The method of claim 17, wherein the EUS-NA device is an EBUS-TBNA device or an EUS-FNA device.

### Claim 19 (depends on 17)

The method of claim 17, further comprising setting a sample needle of an EUS-NA device to a home position.

### Claim 20 (depends on 17)

The method of claim 17, further comprising delivering photodynamic therapy light to the target tissue using the fiber optic cable.

### Claim 21 (depends on 20)

The method of claim 20, wherein the delivered photodynamic therapy light has a wavelength of 400 nm to 1200 nm, or 600 nm to 800 nm, or 630 nm.

### Claim 22 (depends on 17)

The method of claim 17, wherein the fiber optic cable comprises a first optical fiber and a second optical fiber.

### Claim 23 (depends on 20)

The method of claim 20, further comprising:
delivering light to the tissue by way of the first optical fiber; and
receiving a return light from the tissue by way of the second optical fiber.

### Claim 24 (depends on 22)

The method of claim 22, wherein the delivered light is a measurement light, and further comprising characterizing the tissue using the received return light.

### Claim 25 (depends on 23)

The method of claim 23, wherein the measurement light is white light.

### Claim 26 (depends on 17)

The method of claim 17, further comprising unlocking the fiber optic cable from the base and removing the fiber optic cable from the EUS-NA device.

### Claim 27 (depends on 17)

The method of claim 17, further comprising:
advancing the sample needle back over the fiber optic cable;
unlocking the fiber optic cable from the base; and
removing the fiber optic cable from the EUS-NA device.
